◀ Back to MAPK3

MAPK3 — NRG4

Text-mined interactions from Literome

Diamonti et al., Proc Natl Acad Sci U S A 2002 : A putative dominant negative form of Nrdp1 potentiates neuregulin stimulated Erk1/2 activity in transfected MCF7 breast tumor cells
Yuste et al., J Biochem 2005 : Analysis of the action of RasN17 indicated that overexpression of this mutant form of Ras did not affect neuregulin or protein kinase C-induced activation of Erk1/2
Di Segni et al., J Mol Neurosci 2006 : Taken together, these results indicate that in PC12-ErbB4 cells, the NRG induced neuroprotective effect from MPP+ treatment, requires PI3K/PKB/Akt and Ras/MapK signaling networks
Bernard et al., J Biol Chem 2012 (Disease Models, Animal...) : Furthermore, in contrast to related ligands, NRG4 enhanced cell survival but not proliferation or migration, and stimulated phosphorylation of the anti-apoptotic mediator Akt but not ERK MAPK ... Furthermore, in contrast to related ligands, NRG4 enhanced cell survival but not proliferation or migration, and stimulated phosphorylation of the anti-apoptotic mediator Akt but not ERK MAPK